CETEF'24 Partner
MediSensonic
MediSensonic SA is a highly specialised technology company in the Med-Tech area, founded in 2018, specialising in innovative medical and technological solutions. The company currently has several projects in the pipeline, the leading ones at the moment being:
Glucowave – the world’s first fully needle-free, non-invasive device dedicated to glycaemia monitoring,
Touchwave – a state-of-the-art system for blood pressure monitoring without the use of an inflatable cuff
MPVT – a non-invasive microwave dental pulp tester;
The company is led by a skilled management team with engineering skills, cutting-edge management and a highly developed entrepreneurial spirit in its DNA.
The company is a winner of the 2023 Ambassador of Innovation business award and was also among the inspiring group of Laureates of the 2023 Polish Smart Growth Award.
In 2025, MediSensonic plans to apply for prospectus approval and listing of shares on the regulated market of the Warsaw Stock Exchange.
